Related references
Note: Only part of the references are listed.PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress
Mark J. Ranek et al.
NATURE (2019)
Associations Between the Cyclic Guanosine Monophosphate Pathway and Cardiovascular Risk Factors: MESA
Wendy Ying et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure ARIC Study
Roberta Florido et al.
CIRCULATION (2018)
Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance
Patricia P. Chang et al.
CIRCULATION (2018)
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial
Scott D. Solomon et al.
CIRCULATION-HEART FAILURE (2018)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial
Paul W. Armstrong et al.
JACC-HEART FAILURE (2018)
Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Navkaranbir S. Bajaj et al.
JAMA CARDIOLOGY (2018)
Sex Hormones and Change in N-Terminal Pro-B-Type Natriuretic Peptide Levels: The Multi-Ethnic Study of Atherosclerosis
Wendy Ying et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction The INDIE-HFpEF Randomized Clinical Trial
Barry A. Borlaug et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
An NPPB Promoter Polymorphism Associated With Elevated N-Terminal pro-B-Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
Sara B. Seidelmann et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis)
Deepak K. Gupta et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Structure and Activation of Soluble Guanylyl Cyclase, the Nitric Oxide Sensor
William R. Montfort et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
MOLECULAR PHYSIOLOGY OF MEMBRANE GUANYLYL CYCLASE RECEPTORS
Michaela Kuhn
PHYSIOLOGICAL REVIEWS (2016)
25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
Erin D. Michos et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Dong I. Lee et al.
NATURE (2015)
Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure
Milton Packer et al.
CIRCULATION (2015)
Heart Failure With Preserved Ejection Fraction Mechanisms, Clinical Features, and Therapies
Kavita Sharma et al.
CIRCULATION RESEARCH (2014)
Avoiding blunders involving 'immortal time'
James A. Hanley et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Activation of Heme Oxygenase and Suppression of cGMP Are Associated With Impaired Endothelial Function in Obstructive Sleep Apnea With Hypertension
Behrouz Jafari et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
A Genetic Variant of the Atrial Natriuretic Peptide Gene Is Associated With Cardiometabolic Protection in the General Community
Valentina Cannone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Heart Failure With Normal Left Ventricular Ejection Fraction
Micha T. Maeder et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Emily J. Tsai et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Metabolic syndrome and urinary cGMP excretion in general population
Renzhe Cui et al.
ATHEROSCLEROSIS (2007)
Shattuck Lecture: Nitric oxide and cyclic GMP in cell signaling and drug development
Ferid Murad
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relationship between urinary cGMP excretion and serum total cholesterol levels in a general population
RZ Cui et al.
ATHEROSCLEROSIS (2005)
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans
JT Kielstein et al.
CIRCULATION (2004)
Trends in heart failure incidence and survival in a community-based population
VL Roger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Plasma cGMP and large artery remodeling in asymptomatic men
MA Devynck et al.
HYPERTENSION (2004)
Heritability and genetic linkage of plasma natriuretic peptide levels
TJ Wang et al.
CIRCULATION (2003)
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
TW Gress et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
On fitting Cox's proportional hazards models to survey data
DY Lin
BIOMETRIKA (2000)
Share Paper
